# Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
Canonical URL: https://biopharmsignal.com/news/ATRA/atara-biotherapeutics-provides-regulatory-and-business-update-on-ebvallotm-tabelecleucel
Ticker: ATRA
Company: Atara Biotherapeutics, Inc.
Source: Atara Biotherapeutics, Inc.
Published: 2026-01-12 13:00 EST
Original Source URL: https://investors.atarabio.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-12 20:00 EST — [Atara Biotherapeutics Announces Changes to Its Board of Directors](https://biopharmsignal.com/news/ATRA/atara-biotherapeutics-announces-changes-to-its-board-of-directors-7faed22a) — Source: Atara Biotherapeutics, Inc.
- 2026-05-12 20:05 EST — [Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress](https://biopharmsignal.com/news/ATRA/atara-biotherapeutics-announces-first-quarter-2026-financial-results-and-operational-progress) — Source: Atara Biotherapeutics, Inc.
- 2026-05-07 12:05 EST — [Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel](https://biopharmsignal.com/news/ATRA/atara-biotherapeutics-provides-regulatory-update-on-tabelecleucel-36f03b9d) — Source: Atara Biotherapeutics, Inc.
- 2026-03-16 20:05 EST — [Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress](https://biopharmsignal.com/news/ATRA/atara-biotherapeutics-announces-fourth-quarter-and-full-year-2025-financial-results-and-operational-progress) — Source: Atara Biotherapeutics, Inc.
- 2026-03-12 12:05 EST — [Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel](https://biopharmsignal.com/news/ATRA/atara-biotherapeutics-provides-regulatory-update-on-tabelecleucel) — Source: Atara Biotherapeutics, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)